BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10811479)

  • 1. CD83+ human dendritic cells transfected with tumor peptide cDNA by electroporation induce specific T-cell responses: A potential tool for gene immunotherapy.
    Lohmann S; Galle K; Knop J; Enk AH
    Cancer Gene Ther; 2000 Apr; 7(4):605-14. PubMed ID: 10811479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapy.
    Markowicz S; Niedzielska J; Kruszewski M; Ołdak T; Gajkowska A; Machaj EK; Skurzak H; Pojda Z
    Acta Biochim Pol; 2006; 53(1):203-12. PubMed ID: 16404477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes.
    Strobel I; Berchtold S; Götze A; Schulze U; Schuler G; Steinkasserer A
    Gene Ther; 2000 Dec; 7(23):2028-35. PubMed ID: 11175315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transduction of CD34+ cells with lentiviral vectors enables the production of large quantities of transgene-expressing immature and mature dendritic cells.
    Salmon P; Arrighi JF; Piguet V; Chapuis B; Zubler RH; Trono D; Kindler V
    J Gene Med; 2001; 3(4):311-20. PubMed ID: 11529660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation.
    Alijagic S; Möller P; Artuc M; Jurgovsky K; Czarnetzki BM; Schadendorf D
    Eur J Immunol; 1995 Nov; 25(11):3100-7. PubMed ID: 7489749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells.
    Van Tendeloo VF; Snoeck HW; Lardon F; Vanham GL; Nijs G; Lenjou M; Hendriks L; Van Broeckhoven C; Moulijn A; Rodrigus I; Verdonk P; Van Bockstaele DR; Berneman ZN
    Gene Ther; 1998 May; 5(5):700-7. PubMed ID: 9797876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function.
    Jenne L; Hauser C; Arrighi JF; Saurat JH; Hügin AW
    Gene Ther; 2000 Sep; 7(18):1575-83. PubMed ID: 11021596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of tumor-specific T cells by dendritic cells expressing the NY-ESO-1 antigen after transfection with the cationic lipophosphoramide KLN5.
    Le Gallo M; Toutirais O; Montier T; Cabillic F; Bouet F; Delépine P; Lehn P; Jotereau F; Catros V
    J Gene Med; 2008 Jun; 10(6):628-36. PubMed ID: 18338820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA.
    Osman Y; Narita M; Ayres F; Takahashi M; Alldawi L; Tatsuo F; Toba K; Hirohashi T; Aizawa Y
    Cytotherapy; 2003; 5(2):161-8. PubMed ID: 12745578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
    Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy.
    Thurnher M; Papesh C; Ramoner R; Gastl G; Böck G; Radmayr C; Klocker H; Bartsch G
    Exp Hematol; 1997 Mar; 25(3):232-7. PubMed ID: 9091299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced dendritic cell antigen presentation in RNA-based immunotherapy.
    Kalady MF; Onaitis MW; Padilla KM; Emani S; Tyler DS; Pruitt SK
    J Surg Res; 2002 Jun; 105(1):17-24. PubMed ID: 12069496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
    Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
    Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donors.
    Philip R; Brunette E; Ashton J; Alters S; Gadea J; Sorich M; Yau J; O'Donoghue G; Lebkowski J; Okarma T; Philip M
    Cancer Gene Ther; 1998; 5(4):236-46. PubMed ID: 9694075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-free culture of dendritic cells from patients with chronic myeloid leukemia in vitro and estimation of their cytotoxicity.
    Zhao W; Xing P; Wei X; Wang T; Yang D; Li M
    Chin Med J (Engl); 2002 Sep; 115(9):1296-300. PubMed ID: 12411098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary study on fusions of ovarian carcinoma cells to dendritic cell transfected with interleukin-12 gene in vitro].
    Peng P; Shen K; He W; Wu M; Wei W; Lang JH; Zhang SM; Qi J; Hu Y; Zhao JQ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):57-61. PubMed ID: 16635331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
    Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
    Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA.
    Minami K; Yamaguchi Y; Ohshita A; Kawabuchi Y; Ohta K; Hihara J; Toge T
    Oncology; 2005; 69(5):399-407. PubMed ID: 16319511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
    Milano F; van Baal JW; Rygiel AM; Bergman JJ; Van Deventer SJ; Kapsenberg ML; Peppelenbosch MP; Krishnadath KK
    J Immunol Methods; 2007 Apr; 321(1-2):94-106. PubMed ID: 17336322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors.
    Kuppner MC; Gastpar R; Gelwer S; Nössner E; Ochmann O; Scharner A; Issels RD
    Eur J Immunol; 2001 May; 31(5):1602-9. PubMed ID: 11465118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.